Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123945922 | 12394592 | 2 | F | 20160409 | 20160704 | 20160523 | 20160714 | EXP | JP-CELGENEUS-JPN-2016054853 | CELGENE | 72.00 | YR | M | Y | 52.00000 | KG | 20160714 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123945922 | 12394592 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | 200 MILLIGRAM/SQ. METER | U | U | 21660 | 200 | MG/M**2 | INJECTION FOR INFUSION | |||||
| 123945922 | 12394592 | 2 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | U | U | 55974 | 1600 | MG | INJECTION | ||||||
| 123945922 | 12394592 | 3 | C | Artist | CARVEDILOL | 1 | Oral | 1600 MILLIGRAM | 0 | 20 | MG | UNKNOWN | QD | ||||||
| 123945922 | 12394592 | 4 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | UNKNOWN | QD | |||||||
| 123945922 | 12394592 | 5 | C | Candesartan | CANDESARTAN | 1 | Oral | 0 | 8 | MG | UNKNOWN | QD | |||||||
| 123945922 | 12394592 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | UNKNOWN | QD | |||||||
| 123945922 | 12394592 | 7 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 0 | 15 | MG | UNKNOWN | QD | |||||||
| 123945922 | 12394592 | 8 | C | Atorvastatin | ATORVASTATIN | 1 | Oral | 0 | 10 | MG | UNKNOWN | QD | |||||||
| 123945922 | 12394592 | 9 | C | Glactiv | SITAGLIPTIN | 1 | Oral | 0 | 50 | MG | UNKNOWN | QD | |||||||
| 123945922 | 12394592 | 10 | C | Meropenem hydrate | MEROPENEM | 1 | Unknown | 15 MILLIGRAM | 0 | 3 | G | UNKNOWN | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123945922 | 12394592 | 1 | Pancreatic carcinoma |
| 123945922 | 12394592 | 2 | Pancreatic carcinoma |
| 123945922 | 12394592 | 3 | Cardiac failure |
| 123945922 | 12394592 | 4 | Product used for unknown indication |
| 123945922 | 12394592 | 5 | Hypertension |
| 123945922 | 12394592 | 6 | Hypertension |
| 123945922 | 12394592 | 7 | Gastrooesophageal reflux disease |
| 123945922 | 12394592 | 8 | Dyslipidaemia |
| 123945922 | 12394592 | 9 | Diabetes mellitus |
| 123945922 | 12394592 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123945922 | 12394592 | HO |
| 123945922 | 12394592 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123945922 | 12394592 | Ataxia | |
| 123945922 | 12394592 | Diarrhoea | |
| 123945922 | 12394592 | Febrile neutropenia | |
| 123945922 | 12394592 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123945922 | 12394592 | 1 | 20160329 | 20160405 | 0 | |
| 123945922 | 12394592 | 2 | 20160329 | 20160405 | 0 | |
| 123945922 | 12394592 | 5 | 20160331 | 0 | ||
| 123945922 | 12394592 | 10 | 20160412 | 20160418 | 0 |